Is Relay Therapeutics a Buy After Promising Trial Results?
Relay had its initial public offering in 2020. The company's lead therapy is being tested for the treatment of vascular disorders and cancers.
Open original sourceLoading market dashboard
Relay had its initial public offering in 2020. The company's lead therapy is being tested for the treatment of vascular disorders and cancers.
Open original source